| Stage | SPCX | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $14.6B | 100.00% | $96.2B | 100.00% | NVDA ×6.60 |
| Gross profit | $9.1B | 62.42% | $72.1B | 74.98% | NVDA +12.6pp |
| Operating income | $2.8B | 19.15% | $63.7B | 66.24% | NVDA +47.1pp |
| Pre-tax income | $4.0B | 27.54% | $71.5B | 74.32% | NVDA +46.8pp |
| Net income | $4.4B | 30.22% | $59.7B | 62.03% | NVDA +31.8pp |
| Stage | SPCX | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $14.6B100.00% | $96.2B100.00% | NVDA ×6.60 |
| Gross profit | 62.42%$9.1B | 74.98%$72.1B | NVDA +12.6pp |
| Operating income | 19.15%$2.8B | 66.24%$63.7B | NVDA +47.1pp |
| Pre-tax income | 27.54%$4.0B | 74.32%$71.5B | NVDA +46.8pp |
| Net income | 30.22%$4.4B | 62.03%$59.7B | NVDA +31.8pp |
No shared counterparties.